ERG and posterior cortical atrophy: Overall, the study outcomes from the present study are the first of its kind to indicate the benefits of NSAIDs, specifically against TMPSS2-ERG fusion-driven prostate tumorigenesis, which could help in patient stratification in future PCa clinical trials.